Profile
ALIM ZTS TAK HLN TEVA NBIX
Company Name Alimera Sciences, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $293.47M $82.06B $43.45B $42.15B $19.37B $14.77B
Employees 0.15K 14.10K 49.28K 25.41K 35.00K 1.45K
CEO Mr. Richard S. Eiswirth Jr. Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Dr. Kevin C. Gorman Ph.D.
Ratings
ALIM ZTS TAK HLN TEVA NBIX
Quant Rating Score 2 3 2 3 1 3
Quant Rating Sell Neutral Sell Neutral Strong Sell Neutral
Trading
ALIM ZTS TAK HLN TEVA NBIX
Last Close $5.57 $179.84 $13.77 $9.23 $17.1 $146.8
High 52 $5.6 $200.09 $16.32 $9.23 $17.4 $147.46
Low 52 $2.63 $145.54 $12.6 $7.78 $8.12 $101.19
Price vs. 52 Week High -0.54 % -10.12 % -15.63 % 0 % -1.72 % -0.45 %
Price vs. 52 Week Low 111.79 % 23.57 % 9.29 % 18.64 % 110.59 % 45.07 %
Total Return
ALIM ZTS TAK HLN TEVA NBIX
1 Month Return 0.72 % 1.92 % 6.66 % 9.49 % 5.17 % 9.3 %
3 Month Return 59.6 % 13.52 % 5.68 % 9.23 % 23.82 % 7.95 %
6 Month Return 42.09 % -6.1 % -5.68 % 12.97 % 43.58 % 3.27 %
9 Month Return 76.27 % 15.26 % 2.27 % 18.49 % 110.59 % 38.4 %
YTD Return 28.94 % -8.88 % -3.5 % 12.15 % 63.79 % 11.41 %
1 Year Return 64.79 % -4.69 % -11.79 % 6.28 % 103.09 % 44.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALIM ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 0.93 % 4.08 % 2.12 % - -
Dividend Paid and Capex Coverage Ration (TTM) -0.17 % 1.76 % 0.92 % - 3.3 % 20.82 %
Dividend Per Share (TTM) - 1.67 % 0.56 % 0.15 % - -
Payout Ratio (TTM) - 29.95 % 199.34 % - - -
Growth
ALIM ZTS TAK HLN TEVA NBIX
Asset Growth 260.37 % -4.28 % 8.25 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth 32.54 % 3.7 % -16.6 % 5.85 % 9.64 % 26.06 %
Revenue Growth 49.19 % 5.74 % 5.87 % 4.09 % 6.16 % 26.76 %
Revenue 3 Year -68.19 % 31.98 % 33.13 % 13.9 % -6.92 % 71.93 %
Revenue 5 Year -68.61 % 53.64 % 149.89 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year 255.29 % 103.1 % 154.38 % 32.87 % -40.82 % 44100.16 %
EBIT Growth 87.36 % 6.27 % 7.34 % 37.26 % -84.52 % 0.76 %
Net Income Growth -11.18 % 10.88 % -54.56 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 24.51 % 47.55 % -61.74 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share 77.56 % 71.94 % 62.27 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share 96.41 % 404.24 % 36.33 % 59.66 % -133.42 % 470.4 %
Operating Income Growth 87.36 % 6.27 % 7.34 % 37.26 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) -42.97 % 23.06 % -34.47 % -16.48 % -13.96 % 14.88 %
Operating 3 Year CFG -30.19 % 14.12 % -36.76 % 22.08 % 10.09 % 62.6 %
Operating 5 Year CFG 77.46 % 37.69 % 139.61 % 118.54 % -48.98 % 275.6 %
Operating 10 Year CFG 96.89 % 274.61 % 335.67 % 118.54 % -67.94 % 1000.37 %
EPS Growth 69.5 % 12.64 % -54.92 % - 76.42 % 59.01 %
EPS Diluted Growth 69.5 % 12.92 % -54.86 % - 76.42 % 58.33 %
Book Value Per Share 160.62 % 15.34 % 13.54 % 1.38 % -5.72 % 28.15 %
Share Holder 3 Year Equity Growth Per Share 215.86 % 36.7 % 40.38 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share 209.67 % 139.55 % 73.27 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share 177.21 % 476.36 % 197.1 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % - -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 103.93 % -66.42 % -100 % -
Debt Growth 52.04 % -15.91 % 24.67 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth -777.74 % 22.25 % -53.54 % -20.06 % -19.19 % 11.99 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ALIM ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 79.73 % 69.2 % 66.54 % 60.04 % 48.99 % 97.78 %
Return on Assets TTM -14.04 % 16.66 % 0.95 % - -1.15 % 10.65 %
Return on Equity TTM -47.09 % 48.41 % 2.06 % 6.53 % -6.86 % 17.45 %
Return on Capital Employed TTM -0.22 % 25.86 % 3.22 % - 3.75 % 17.05 %
Net Income Per EBT TTM 99.75 % 80.07 % 293.72 % 64.62 % 59.18 % 78.68 %
EBT Per Ebit TTM 7277.29 % 92.82 % 11.92 % 82.52 % -76.63 % 99.89 %
EBIT Per Revenue TTM -0.33 % 36.83 % 9.65 % 18.08 % 6.79 % 23.73 %
Cash Flow To Debt Ratio TTM -17.96 % 36.43 % 14.47 % - 8.57 % 118.01 %
Receivables Turnover TTM 2.64 6.75 6.11 - 4.63 4.4
Payables Turnover TTM 1.77 6.64 4.46 - 3.35 0.5
Inventory Turnover TTM 8.29 1.01 1.18 - 2.07 1.18
Fixed Asset Turnover TTM 2624.93 % 251.27 % 214.28 % - 267.75 % 572.67 %
Asset Turnover TTM 59.17 % 60.87 % 28.22 % - 37.45 % 57.08 %
Operating Cash Flow Per Share TTM -0.23 5.24 452.66 - 1.5 6.47
Free Cash Flow Per Share TTM -1.62 3.82 146.27 - 1.04 6.16
Cash Per Share TTM 26.39 % 431.22 % 29177.57 % 22.71 % 266.34 % 1213.03 %
Operating Cash Flow Sales Ratio TTM -13.99 % 27.47 % 16.66 % - 10.51 % 32.56 %
Free Cash Flow Operating Cash Flow Ratio TTM 698.7 % 72.95 % 32.31 % - 69.66 % 95.2 %
Cash Flow Coverage Ratios TTM -17.96 % 36.43 % 14.47 % - 8.57 % 118.01 %
Price To Free Cash Flows Ratio TTM -3.33 46.89 29.1 - 16.51 24.05
Price To Operating Cash Flows Ratio TTM -23.99 34.33 4.68 - 11.4 22.7
Price Cash Flow Ratio TTM -23.99 34.33 4.68 - 11.4 22.7
Income Statement (TTM)
ALIM ZTS TAK HLN TEVA NBIX
Revenue $0.08B $8.54B $4263.76B $11.3B $15.85B $1.89B
Gross Profit $0.06B $5.83B $2321.31B $6.96B $7.65B $1.85B
Gross Profit Ratio 75.75% 68.28% 54.44% 61.6% 48.25% 97.9%
EBITDA $0.01B $3.56B $1254.52B $2.81B $4.27B $0.42B
Net Income $-0.02B $2.34B $144.07B $1.05B $-0.56B $0.25B
EPS Diluted -0.79 5.07 91.16 0.11 -0.5 2.47
Balance Sheet (MRQ)
ALIM ZTS TAK HLN TEVA NBIX
Long Term Debt $0.06B $6.56B $4476.5B $8.8B $18.48B $0.26B
Total Liabilities $0.11B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $0.05B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $0B $0.02B $683.22B $0.07B $0.01B $0.94B
Total Debt $0.07B $6.8B $5463.39B $9.46B $20.15B $0.43B
Total Assets $0.15B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
ALIM ZTS TAK HLN TEVA NBIX
Net Income $-0.02B $2.34B $144.07B $1.05B $-0.62B $0.25B
Inventory $-0B $-0.36B $-115.74B $-0.13B $-0.15B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $-0.01B $2.35B $640.32B $1.72B $1.37B $0.39B
Capital Expenditure $-0.08B $-0.73B $-480.73B $-0.34B $-0.53B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.9
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.45
AKAN Akanda Corp. 1.63
ALVO Alvotech 11.59
ALVOW Alvotech 2.59
AMPH Amphastar Pharmaceuticals, Inc. 42.48
AMRX Amneal Pharmaceuticals, Inc. 7.44
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 63.25
AQST Aquestive Therapeutics, Inc. 3.82
ASRT Assertio Holdings, Inc. 1.505
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 16.72
AYTU Aytu BioPharma, Inc. 2.7
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ALIM
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00445 224.22
VTI Vanguard Total Stock Market Index Fund 0 269.69
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 119.77
IWN iShares Russell 2000 Value ETF 0.00102 171.34
IWO iShares Russell 2000 Growth ETF 0.00805 284.97
VXF Vanguard Extended Market Index Fund 0 178.79
HDG ProShares Hedge Replication ETF 0.000854253 49.94
UWM ProShares Ultra Russell2000 0.00109985 45.01
VTHR Vanguard Russell 3000 Index Fund 0 241.43
IWC iShares Micro-Cap ETF 0.02926 129.25
URTY ProShares UltraPro Russell2000 0.000481664 57.06
VTWV Vanguard Russell 2000 Value Index Fund 0 150.96
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 207.52
VTWO Vanguard Russell 2000 Index Fund 0 90.66
DFUS Dimensional U.S. Equity ETF 0 59.2
DFAC Dimensional U.S. Core Equity 2 ETF 0 33.02
VTSAX Vanguard Total Stock Market Index Fund 0 131.27
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VITSX Vanguard Total Stock Market Index Fund 0 131.29
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 246.27
RSSL Global X Funds 0 88.2379
Unlock